The IRMA Community
Newsletters
Research IRM
Click a keyword to search titles using our InfoSci-OnDemand powered search:
|
Transformative Approaches in Breast Cancer Treatment: The Role of Polymers, Biomaterials, Nanomaterials, and Metal Ions
|
|
Author(s): Navya Aggarwal (Amity University, New Delhi, India), Shinjini Sen (Amity University, New Delhi, India), Tanmay J. Urs (Amity University, New Delhi, India), Shreya Gupta (Amity University, New Delhi, India)and Banashree Bondhopadhyay (Amity University, New Delhi, India)
Copyright: 2026
Pages: 36
Source title:
Biomedical Applications and Toxicity of Polymers, Nanoparticles, Biomaterials, and Metal Ions
Source Author(s)/Editor(s): Deniz Eren Erişen (Institute of Semiconductors, Guangdong Academy of Sciences, China), Faez Iqbal Khan (Xi’an Jiaotong-Liverpool University, China), Cheng Chang (Institute of New Materials, Guangdong Academy of Sciences, China & University of Birmingham, UK)and Kai-Cheng Yan (University of Bath, UK)
DOI: 10.4018/979-8-3373-0055-9.ch007
Purchase
|
Abstract
The transformative role of polymers, biomaterials, nanomaterials, and metal ions in breast cancer treatment have highlighted their potential to enhance diagnosis and therapeutic outcomes. Traditional cancer therapies have often fallen short due to their “one-size-fits-all” approach, leading to increased patient non-responsiveness. The integration of interdisciplinary research—from biomedical science to nanotechnology—promises more precise and effective treatments. Polymers enable targeted drug delivery with reduced side effects, while biomaterials enhance regeneration and drug delivery systems. Nanomaterials improve drug accumulation in tumors and combat resistance, and metal ions disrupt cancer cell metabolism and DNA. By exploring case studies and applications of these advanced materials, this paper underscores their significant contributions to personalized cancer therapies and improved patient quality of life. Looking forward, innovations in multifunctional nanomaterials and biosensors are anticipated to further revolutionize breast cancer treatment strategies.
Related Content
|
Saloua Mabsor-Zgandaoui, Khawla Rachmoune, Ilham Aftais, Fatima Ezzahra Elamrani, Imade Amradi, Adil El Housseini, Youssef Ait Hamdan, Youness Zgandaoui, Abdelghani Iddar, Mohammed El Mzibri, Adnane Moutaouakkil, Aboubaker El Hessni, Abdelhalim Mesfioui.
© 2026.
30 pages.
|
|
Yusuf Olatunji Waidi.
© 2026.
20 pages.
|
|
Ajinkya Nene, Sorour Sadeghzade, Wenjie Yang, Prakash Somani.
© 2026.
12 pages.
|
|
Seyyed Mohammad Amin Mousavi-Sagharchi, Mahdieh Ranjbar-Jamalabadi, Sama Yavari, Elina Afrazeh, Naresh Poondla, Mohsen Sheykhhasan.
© 2026.
32 pages.
|
|
Wenqiang Xie, Yuan Su, Ruiqi Zhang, Sijia Li, Jia Ni, Longquan Shao.
© 2026.
18 pages.
|
|
Zhengao Wang, Huiyu Zhao, Yao Han, Wuyi Zhou, Chengyun Ning.
© 2026.
30 pages.
|
|
Navya Aggarwal, Shinjini Sen, Tanmay J. Urs, Shreya Gupta, Banashree Bondhopadhyay.
© 2026.
36 pages.
|
|
|